Want to track EGTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Egetis Therapeutics AB (EGTX) Statistics
Valuation metrics
Market Cap 3.13B
Enterprise value 2.28B
Trailing P/E (ttm) -6.26
Forward P/E -
PEG ratio -1.52
Price/Sales (ttm) 37.07
Price/Book (mrq) 9.86
Enterprise Value/Revenue 36
Enterprise Value/EBITDA -6.36
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 532.73K
Average volume (90 days) 847.46K
Price summary
52-Week low 3.12
52-Week high 7.07
Beta -
50-Day moving average 5.69
200-Day moving average 5.46
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -5.92%
Operating margin -5.87%
Operational effectiveness
Return on assets -0.7%
Return on equity -1.23%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.16
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.95
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.36
Total debt (mrq) -
Total Debt/Equity (mrq) 0.3
Current ratio (mrq) 0.69%
Book value per share (mrq) 0.63
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
